234 related articles for article (PubMed ID: 12739233)
1. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage.
Thiex R; Küker W; Müller HD; Rohde I; Schröder JM; Gilsbach JM; Rohde V
Neurol Res; 2003 Apr; 25(3):254-62. PubMed ID: 12739233
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.
Rohde V; Rohde I; Thiex R; Ince A; Jung A; Dückers G; Gröschel K; Röttger C; Küker W; Müller HD; Gilsbach JM
J Neurosurg; 2002 Oct; 97(4):954-62. PubMed ID: 12405387
[TBL] [Abstract][Full Text] [Related]
3. Minor inflammation after surgical evacuation compared with fibrinolytic therapy of experimental intracerebral hemorrhages.
Thiex R; Küker W; Jungbluth P; Kayser C; Müller HD; Rohde I; Gilsbach JM; Rohde V
Neurol Res; 2005 Jul; 27(5):493-8. PubMed ID: 15978174
[TBL] [Abstract][Full Text] [Related]
4. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection.
Wagner KR; Xi G; Hua Y; Zuccarello M; de Courten-Myers GM; Broderick JP; Brott TG
J Neurosurg; 1999 Mar; 90(3):491-8. PubMed ID: 10067918
[TBL] [Abstract][Full Text] [Related]
5. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.
Mould WA; Carhuapoma JR; Muschelli J; Lane K; Morgan TC; McBee NA; Bistran-Hall AJ; Ullman NL; Vespa P; Martin NA; Awad I; Zuccarello M; Hanley DF;
Stroke; 2013 Mar; 44(3):627-34. PubMed ID: 23391763
[TBL] [Abstract][Full Text] [Related]
7. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages.
Thiex R; Weis J; Krings T; Barreiro S; Yakisikli-Alemi F; Gilsbach JM; Rohde V
J Neurosurg; 2007 Feb; 106(2):314-20. PubMed ID: 17410717
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous versus exogenous tPA on edema formation in murine ICH.
Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA
Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833
[TBL] [Abstract][Full Text] [Related]
9. The effect of monascin on hematoma clearance and edema after intracerebral hemorrhage in rats.
Wang J; Wang G; Yi J; Xu Y; Duan S; Li T; Sun XG; Dong L
Brain Res Bull; 2017 Sep; 134():24-29. PubMed ID: 28655601
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
[TBL] [Abstract][Full Text] [Related]
11. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter.
Wagner KR; Xi G; Hua Y; Kleinholz M; de Courten-Myers GM; Myers RE; Broderick JP; Brott TG
Stroke; 1996 Mar; 27(3):490-7. PubMed ID: 8610319
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of brain edema formation.
Xi G; Keep RF; Hoff JT
Neurosurg Clin N Am; 2002 Jul; 13(3):371-83. PubMed ID: 12486926
[TBL] [Abstract][Full Text] [Related]
13. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data.
Rohde V; Uzma N; Thiex R; Samadani U
Acta Neurochir Suppl; 2008; 105():101-4. PubMed ID: 19066092
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats.
Deinsberger W; Vogel J; Fuchs C; Auer LM; Kuschinsky W; Böker DK
Neurol Res; 1999 Jul; 21(5):517-23. PubMed ID: 10439435
[TBL] [Abstract][Full Text] [Related]
15. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
Schaller C; Rohde V; Hassler W
Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814
[TBL] [Abstract][Full Text] [Related]
16. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
[TBL] [Abstract][Full Text] [Related]
17. Intraclot recombinant tissue-type plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage.
Lian LF; Xu F; Tang ZP; Xue Z; Liang QM; Hu Q; Zhu WH; Kang HC; Liu XY; Wang FR; Zhu SQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):165-171. PubMed ID: 24710926
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous intracerebral hemorrhage in humans: hematoma enlargement, clot lysis, and brain edema.
Wu G; Xi G; Huang F
Acta Neurochir Suppl; 2006; 96():78-80. PubMed ID: 16671430
[TBL] [Abstract][Full Text] [Related]
19. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages.
Thiex R
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):150-6. PubMed ID: 21521167
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator.
Schaller C; Rohde V; Meyer B; Hassler W
Neurosurgery; 1995 Feb; 36(2):328-33; discussion 333-5. PubMed ID: 7731513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
